Clinical Trials Logo

Clinical Trial Summary

The investigators aimed to assess if use of aromatase inhibitors could decrease volume of uterine leiomyoma and cause same percentage of adverse effects during its use compared to GnRH analogs.


Clinical Trial Description

Uterine leiomyoma is the most prevalent benign gynecologic tumor in women. Standard treatment is surgical (hysterectomy or myomectomy), and depends of many variables. If these tumors are large, preoperative assessment with clinical treatment may be useful in order to decrease its volume, improve hematologic patterns and modify surgical approach (vaginal or abdominal). It is well know that GnRH analogs can cause these goals; however, aromatase inhibitors are new promising drugs which are being used for reducing uterine leiomyoma's volume and few observational studies have shown this fact. The investigators are aiming to compare both treatments in a randomized controlled trial and see if it both treatments are similar or not in decreasing uterine leiomyoma's volume, influencing operative time, blood loss during surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01280045
Study type Interventional
Source University of Sao Paulo
Contact
Status Terminated
Phase N/A
Start date January 2011
Completion date January 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Not yet recruiting NCT03219385 - Directed Ablation of Uterine Fibroids Using a Noninvasive Approach N/A
Completed NCT01338831 - Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer Phase 1
Completed NCT01468402 - Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma N/A
Completed NCT03847077 - Trial of a Patient Education Tool For Leiomyoma N/A
Completed NCT00365989 - MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Phase 3
Completed NCT03751124 - Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Phase 3
Recruiting NCT02495311 - The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
Completed NCT00332033 - Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) Phase 2
Completed NCT04874246 - Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy N/A
Not yet recruiting NCT04282863 - Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM) N/A
Recruiting NCT06115408 - Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma Phase 2/Phase 3
Completed NCT02049242 - Uterine Tourniquet at Open Myomectomy N/A
Completed NCT02059954 - Vaginal vs. Laparoscopic Hysterectomy N/A
Terminated NCT01738724 - Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin Phase 4
Withdrawn NCT02736435 - Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound Phase 3
Completed NCT04819633 - Evaluating Serum Sestrin in Leiomyoma Patients
Completed NCT00341848 - Postpartum Uterine Regression
Completed NCT01715597 - Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma Phase 3
Completed NCT03328260 - High Intensity Focused Ultrasound in Uterine Myoma N/A